AI assistant
Sending…
Century Therapeutics, Inc. — Director's Dealing 2021
Jun 21, 2021
34658_dirs_2021-06-21_f50f2ef6-d11a-4555-8b72-89b37bb1a552.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2021-06-17
Reporting Person: Carlo Rizzuto (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-17 | Option (right to buy) | $20 | A | 39744 | Acquired | 2031-06-17 | Common Stock (39744) | Direct |
Footnotes
F1: The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting date.
More from Century Therapeutics, Inc.
Regulatory Filings
2026
Jun 8
Capital/Financing Update
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Capital/Financing Update
2026
Feb 5
Director's Dealing
2026
Feb 4